These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5153309)

  • 1. [Studies on the analgetic effects of MAO inhibitors].
    Fähse C; Matthies H
    Acta Biol Med Ger; 1971; 26(6):1215-21. PubMed ID: 5153309
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.
    Rogers KJ; Thornton JA
    Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 5. [The importance of central monoaminergic mechanisms in the effect of pharmacologic substances on the reflex reactions of the heart].
    Kaverina NV; Mirzoian RS; Rozonov IuB
    Biull Eksp Biol Med; 1967 Jun; 63(6):59-64. PubMed ID: 4393562
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
    Goldwurm GF; Torrigiani G
    Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic effect on the adrenergic mechanisms of heart blood supply regulation].
    Zakusov VV; Kaverina NV
    Kardiologiia; 1967 Nov; 7(11):45-54. PubMed ID: 4979866
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of peripheral serotonin antagonists and monoamine oxidase inhibitors on some central effects of indolalkylamines].
    Gilev AP; Tetenchuk EV
    Farmakol Toksikol; 1968; 31(2):159-63. PubMed ID: 5674667
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of monoamine oxidase inhibitors on the cardiovascular action of some analgesics.
    Jounela AJ
    Ann Med Exp Biol Fenn; 1970; 48(4):249-60. PubMed ID: 5492145
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of adrenergic drugs on morphine-induced hyperglycemia.
    Clissiounis N
    Life Sci; 1979 Jul; 25(4):391-4. PubMed ID: 470556
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between histamine and monoamine oxidase inhibitors.
    Allen GS; Rand MJ
    J Pharm Pharmacol; 1969 May; 21(5):317-22. PubMed ID: 4390125
    [No Abstract]   [Full Text] [Related]  

  • 14. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of thyroid monoamineoxidase by thyroxine and some specific inhibitors.
    Knopp J; Torda T
    Endokrinologie; 1979; 73(3):356-8. PubMed ID: 499103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New data on monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1971; 26(11):23-8. PubMed ID: 4942003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP; Samsonova ML
    Farmakol Toksikol; 1969; 32(5):526-30. PubMed ID: 5364661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between the anti-inflammatory effect and inhibiting activity of monoaminoxidase inhibitors].
    Trinus FP; Riabukha TK
    Farmakol Toksikol; 1973; 36(1):84-9. PubMed ID: 4685161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental sleep by non-barbiturate hypnotics and modifiers of hepatic microsome activity].
    Boismare F; Camacho M; Lechat P
    Therapie; 1969; 24(6):949-54. PubMed ID: 5367189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.